| Ral GTPases promote breast cancer metastasis by controlling biogenesis and organ targeting of exosomes S Ghoroghi, B Mary, A Larnicol, N Asokan, A Klein, N Osmani, I Busnelli, ... Elife 10, e61539, 2021 | 105 | 2021 |
| Optimal physicochemical properties of antibody–nanoparticle conjugates for improved tumor targeting V Mittelheisser, P Coliat, E Moeglin, L Goepp, JG Goetz, LJ Charbonnière, ... Advanced Materials 34 (24), 2110305, 2022 | 33 | 2022 |
| Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases V Mittelheisser, V Gensbittel, L Bonati, W Li, L Tang, JG Goetz Nature Nanotechnology 19 (3), 281-297, 2024 | 23 | 2024 |
| Platelets favor the outgrowth of established metastases MJ Garcia-Leon, C Liboni, V Mittelheisser, L Bochler, G Follain, ... Nature Communications 15 (1), 3297, 2024 | 15 | 2024 |
| Anti‐BCMA Immuno‐NanoPET Radiotracers for Improved Detection of Multiple Myeloma E Thomas, C Mathieu, P Moreno‐Gaona, V Mittelheisser, F Lux, ... Advanced Healthcare Materials 11 (2), 2101565, 2022 | 9 | 2022 |
| Helios represses megakaryocyte priming in hematopoietic stem and progenitor cells G Cova, C Taroni, MC Deau, Q Cai, V Mittelheisser, M Philipps, M Jung, ... Journal of Experimental Medicine 218 (10), e20202317, 2021 | 8 | 2021 |
| Peripheral positioning of lysosomes supports melanoma aggressiveness K Jerabkova-Roda, M Peralta, KJ Huang, CB Maudru, L Bochler, ... bioRxiv, 2023.07. 07.548108, 2023 | 5 | 2023 |
| Leveraging immunotherapy with nanomedicine V Mittelheisser, M Banerjee, X Pivot, LJ Charbonnière, J Goetz, ... Advanced Therapeutics 3 (12), 2000134, 2020 | 4 | 2020 |
| Nanomaterials trigger functional responses in primary human immune cells V Mittelheisser, O Lefebvre, M Banerjee, S Ghosh, A Dupas, MC Diringer, ... bioRxiv, 2024.10. 17.618911, 2024 | | 2024 |
| Targeting monocytic Occludin impairs transendothelial migration and HIV neuroinvasion D Brychka, NV Ayala-Nunez, A Dupas, Y Bare, E Partiot, V Mittelheisser, ... EMBO reports 25 (8), 3276-3299, 2024 | | 2024 |
| Reinforced polymer–nanoparticle hydrogels for subcutaneous and sustained delivery of trastuzumab G Bovone, S Bernhard, G Jacquot, V Mittelheisser, C Mirjolet, EA Guzzi, ... bioRxiv, 2024.07. 30.605810, 2024 | | 2024 |
| Cell viscosity influences hematogenous dissemination and metastatic extravasation of tumor cells V Gensbittel, G Follain, L Bochler, K Uhlmann, O Lefèbvre, A Larnicol, ... bioRxiv, 2024.03. 28.587171, 2024 | | 2024 |
| Depletion of all platelet integrins impacts hemostasis, thrombosis and tumor metastasis E Janus-Bell, C Liboni, A Yakusheva, V Mittelheisser, C Mouriaux, ... bioRxiv, 2024.11. 22.624871, 2024 | | 2024 |
| Developing new strategies to control tumour progression-Targeting tumors or the immune system, a paradigm shift. V Mittelheisser, O Lefebvre, R Soltani, S Ghosh, M Diringer, C Mathieu, ... EUROPEAN JOURNAL OF IMMUNOLOGY 53, 173-173, 2023 | | 2023 |
| Age-related effects on tumor growth and metastatic progression: impact on immune populations in distant sites C Liboni, L Bochler, F Colin, A Larnicol, V Mittelheisser, N Osmani, ... EUROPEAN JOURNAL OF IMMUNOLOGY 53, 170-170, 2023 | | 2023 |
| P09. 22 Toward a rational design of immunonanotherapies V Mittelheisser, X Coubez, O Lefebvre, JG Goetz, A Detappe Journal for ImmunoTherapy of Cancer 10 (Suppl 1), 2022 | | 2022 |
| Conjugués anticorps-nanoparticules: nouvelles perspectives thérapeutiques en oncologie V Mittelheisser Faculté de Pharmacie, Université de Strasbourg, 2021 | | 2021 |